Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Post by Lookingforclueson Jul 24, 2020 8:29am

135 Views

Post# 31312896

Just a mess!

Will the Populace wait another 5/10 years?
Now that is a good Q!
Gold/silver is on it's way to a Record price.
Perhaps the Stalwart GUD players will re consider.
Goodman's play on GUD/GOOD was cute, but when one can triple their money in other Equities, particularly when Gold/Silver was pretty well guaranteed to increase, can they ignore it.
And it is still on it's way up!
Hear Ye...Hear Ye!

Bullboard Posts

They started in video game investing, now they serve high net worth traders